oxybutynin has been researched along with aminolevulinic acid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Donnelly, RF; McCarron, PA; Morrow, DI; Woolfson, AD | 1 |
| Hauschild, A; Moor, AC; Ortland, C; Stocker, M; Surber, C; Szeimies, RM | 1 |
| Braathen, LR | 1 |
| Du, J; Li, X; Wang, Y; Zhang, P; Zhao, X | 1 |
| Bianchi, L; Campione, E; Dattola, A; De Luca, EV; Fargnoli, MC; Garofalo, V; Gutiérrez Garcìa-Rodrigo, C; Lappi, A; Peris, K; Tambone, S | 1 |
5 other study(ies) available for oxybutynin and aminolevulinic acid
| Article | Year |
|---|---|
Fast-drying multi-laminate bioadhesive films for transdermal and topical drug delivery.
Topics: Adhesiveness; Administration, Cutaneous; Aminolevulinic Acid; Animals; Animals, Newborn; Chemical Phenomena; Drug Compounding; Drug Delivery Systems; Hydrophobic and Hydrophilic Interactions; Materials Testing; Mechanical Phenomena; Models, Molecular; Nicotine; Nicotinic Agonists; Photosensitizing Agents; Quality Control; Skin; Solubility; Sus scrofa; Tensile Strength; Transdermal Patch; Volatilization | 2013 |
Photodynamic therapy simplified: nonprepared, moderate-grade actinic keratosis lesions respond equally well to 5-aminolaevulinic acid patch photodynamic therapy as do mild lesions.
Topics: Aminolevulinic Acid; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Randomized Controlled Trials as Topic; Transdermal Patch; Treatment Outcome | 2015 |
Successful Daylight-PDT using a self-adhesive 5-aminolaevulinic acid patch.
Topics: Adhesives; Aged, 80 and over; Aminolevulinic Acid; Humans; Keratosis, Actinic; Male; Photochemotherapy; Photosensitizing Agents; Sunlight; Transdermal Patch | 2018 |
Tip-loaded fast-dissolving microneedle patches for photodynamic therapy of subcutaneous tumor.
Topics: Administration, Cutaneous; Aminolevulinic Acid; Animals; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Equipment Design; Humans; Hyaluronic Acid; Male; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Photochemotherapy; Photosensitizing Agents; Rats, Sprague-Dawley; Solubility; Transdermal Patch | 2018 |
5-Aminolaevulinic acid patch photodynamic therapy for the treatment of actinic keratoses: preliminary results from an Italian study in the real-life setting.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Female; Humans; Italy; Keratosis, Actinic; Levulinic Acids; Male; Middle Aged; Photochemotherapy; Retrospective Studies; Transdermal Patch; Treatment Outcome | 2020 |